Stock GENI GENERIC SWEDEN AB
Add to a list
To use this feature you must be a member
Log inSign up

Financials Generic Sweden AB

Equities

GENI

SE0001790791

Business Support Services

Delayed Nasdaq Stockholm
Other stock markets
 03:19:31 2024-07-11 am EDT 		5-day change 1st Jan Change
44.5 SEK -0.67% Intraday chart for Generic Sweden AB -1.55% -14.09%
May. 15 Generic Sweden AB Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Feb. 15 Generic Sweden AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 244.6 510.1 1,013 417.9 636.7 550.7 - -
Enterprise Value (EV) 1 224.3 487.6 981.8 417.9 611.5 516.7 509.7 500.7
P/E ratio 27.6 x 47.2 x 56.1 x 20.5 x 27.3 x 21.1 x 17.4 x 15.4 x
Yield 4.02% 1.93% 1.21% - 2.9% 3.91% 4.46% 5.02%
Capitalization / Revenue 3.53 x 6.29 x 8.87 x 3.27 x 4.47 x 3.2 x 2.78 x 2.53 x
EV / Revenue 3.24 x 6.01 x 8.59 x 3.27 x 4.29 x 3 x 2.58 x 2.3 x
EV / EBITDA 17.7 x 32.1 x 40.6 x 15.5 x 20.8 x 15.8 x 12.8 x 11.1 x
EV / FCF 28.9 x 38.2 x 54.6 x - 30.6 x 18.5 x 17.6 x 14.7 x
FCF Yield 3.46% 2.62% 1.83% - 3.27% 5.42% 5.69% 6.79%
Price to Book 11.6 x 23.2 x 33.4 x - 13.7 x 10.3 x 8.68 x 7.39 x
Nbr of stocks (in thousands) 12,292 12,292 12,292 12,292 12,292 12,292 - -
Reference price 2 19.90 41.50 82.40 34.00 51.80 44.80 44.80 44.80
Announcement Date 2/13/20 2/18/21 2/17/22 2/16/23 2/15/24 - - -
1SEK in Million2SEK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 69.28 81.08 114.2 127.7 142.6 172.1 197.9 217.7
EBITDA 1 12.7 15.2 24.2 26.9 29.38 32.6 39.8 45.1
EBIT 1 11.23 13.81 22.84 25.76 28.61 31.8 38.8 44.1
Operating Margin 16.21% 17.04% 19.99% 20.17% 20.06% 18.48% 19.61% 20.26%
Earnings before Tax (EBT) 1 11.26 13.82 22.85 25.77 29.38 32.8 39.8 44.9
Net income 1 8.801 10.84 18.13 20.44 23.31 26.1 31.6 35.6
Net margin 12.7% 13.37% 15.87% 16.01% 16.35% 15.17% 15.97% 16.35%
EPS 2 0.7200 0.8800 1.470 1.660 1.900 2.120 2.570 2.900
Free Cash Flow 1 7.753 12.75 17.98 - 19.97 28 29 34
FCF margin 11.19% 15.73% 15.74% - 14% 16.27% 14.65% 15.62%
FCF Conversion (EBITDA) 61.05% 83.91% 74.31% - 67.96% 85.89% 72.86% 75.39%
FCF Conversion (Net income) 88.09% 117.64% 99.21% - 85.66% 107.28% 91.77% 95.51%
Dividend per Share 2 0.8000 0.8000 1.000 - 1.500 1.750 2.000 2.250
Announcement Date 2/13/20 2/18/21 2/17/22 2/16/23 2/15/24 - - -
1SEK in Million2SEK
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 30.53 31.9 31.33 30.25 34.24 34.64 34.59 34.8 38.64 42.17 41.9 41.3 46.8
EBITDA 1 5.5 6.631 5.752 6.953 7.6 7.6 7.1 8.012 6.7 7.138 7.6 8.9 8.9
EBIT 1 5.117 6.268 5.397 6.728 7.37 7.391 6.907 7.831 6.478 6.884 7.4 8.7 8.7
Operating Margin 16.76% 19.65% 17.23% 22.24% 21.52% 21.34% 19.97% 22.5% 16.77% 16.33% 17.66% 21.07% 18.59%
Earnings before Tax (EBT) 1 5.129 6.262 5.392 6.727 7.388 7.447 6.99 7.924 7.019 7.031 7.7 9 9
Net income 1 4.056 4.972 4.282 5.341 5.85 5.913 5.55 6.285 5.561 5.583 6.1 7.2 7.1
Net margin 13.28% 15.58% 13.67% 17.66% 17.08% 17.07% 16.05% 18.06% 14.39% 13.24% 14.56% 17.43% 15.17%
EPS 2 0.3300 0.4000 0.3500 0.4300 0.4800 0.4800 0.4300 0.5100 0.4500 0.4500 0.5000 0.5800 0.5800
Dividend per Share - - - - - - - - - - - - -
Announcement Date 2/17/22 5/18/22 8/25/22 11/17/22 2/16/23 5/16/23 8/24/23 11/16/23 2/15/24 5/15/24 - - -
1SEK in Million2SEK
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - - -
Net Cash position 1 20.3 22.5 31.1 - 25.2 34 41 50
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 7.75 12.8 18 - 20 28 29 34
ROE (net income / shareholders' equity) 40.9% 50.4% 69.3% - 54.9% 52.2% 54.1% 51.7%
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share 2 1.710 1.790 2.470 - 3.780 4.340 5.160 6.060
Cash Flow per Share - - - - - - - -
Capex 1 0.86 0.35 0.5 - 1.87 1 1 1
Capex / Sales 1.24% 0.44% 0.44% - 1.31% 0.58% 0.51% 0.46%
Announcement Date 2/13/20 2/18/21 2/17/22 2/16/23 2/15/24 - - -
1SEK in Million2SEK
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Generic Sweden AB

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Business Support Services

1st Jan change Capi.
GENERIC SWEDEN AB Stock Generic Sweden AB
-14.09% 52.24M
CINTAS CORPORATION Stock Cintas Corporation
+18.77% 72.62B
JACOBS SOLUTIONS INC. Stock Jacobs Solutions Inc.
+6.76% 17.35B
RB GLOBAL, INC. Stock RB Global, Inc.
+15.68% 14.15B
BUREAU VERITAS SA Stock Bureau Veritas SA
+14.65% 12.84B
INTERTEK GROUP PLC Stock Intertek Group plc
+11.87% 9.86B
TELEPERFORMANCE SE Stock Teleperformance SE
-18.25% 6.97B
GENPACT LIMITED Stock Genpact Limited
-10.57% 5.59B
EXLSERVICE HOLDINGS, INC. Stock ExlService Holdings, Inc.
+1.69% 5.1B
MAXIMUS, INC. Stock Maximus, Inc.
+1.73% 5.19B
Other Business Support Services
  1. Stock Market
  2. Equities
  3. GENI Stock
  4. Financials Generic Sweden AB